RecruitingNCT06917339

Retrospective Analyses of TrakStar Database

Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes


Sponsor

Neuronetics

Enrollment

156,000 participants

Start Date

Feb 25, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.


Eligibility

Min Age: 5 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This is a retrospective study — meaning researchers are looking back at already-collected medical records rather than testing a new treatment. The study analyzes data from the TrakStar Database to better understand patterns and outcomes related to past medical treatments. If your information is already in the database, you may be considered for inclusion without any additional action on your part. **You may be eligible if...** - Your records are already stored in the TrakStar database with valid entries - Your treatment date is from November 1, 2008 or later - Your age and gender are correctly recorded in the database **You may NOT be eligible if...** - Your treatment records are incomplete or contain invalid data entries Because this study only reviews existing records, there is no active participation required and no new treatments or procedures involved. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENeuroStar Advanced TMS Therapy System

non-invasive brain stimulation device


Locations(1)

Neuronetics

Malvern, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06917339


Related Trials